Generate:Biomedicines Announces Publication of its Chroma Model in Nature
SOMERVILLE, Mass.--(BUSINESS WIRE)--Generate:Biomedicines today announced that Dr. Alexandra (Alex) Snyder has been appointed to Executive Vice President, Research & Development, in addition to her current responsibilities as Chief Medical Officer, effective immediately. In her new role, Dr. Snyder will leverage her extensive clinical and scientific experience to help the company advance its generative AI pipeline of protein therapeutics to clinical stage.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Generate Biomedicines today announced that it will participate in the 41st Annual J.P. Morgan Healthcare Conference in San Francisco later this month.
Generate Biomedicines Expands Board of Directors With Jane Mendillo, Former CEO of The Harvard Management Company
Generate Biomedicines Demonstrates a Novel Method of Reducing Immunogenicity through Protein Re-surfacing
Generate Biomedicines Expands Leadership Team with Chief Digital Officer
Generate Biomedicines Uses AI to Create Proteins That Have Never Existed
Generate Biomedicines Grows Leadership Team with Head of Vaccines and Infectious Disease Research and Senior Vice President of Technical Operations
SOMERVILLE, Mass.--(BUSINESS WIRE)--Generate Biomedicines, whose machine learning-powered generative biology platform can rapidly invent new drugs across a wide range of protein modalities and previously undiscoverable protein therapeutics, today announced that Alexandra Snyder, M.D. has been named Chief Medical Officer to oversee all clinical matters.
SOMERVILLE, Mass.--(BUSINESS WIRE)--Generate Biomedicines, whose machine learning-powered generative biology platform can rapidly invent new drugs across a wide range of protein modalities and previously undiscoverable protein therapeutics, today announced that Jason Silvers, M.D., J.D., has been named the company’s Chief Financial Officer, overseeing all financial matters as the company advances into its next stage of growth.